| Poverty and cognitive function EB Dean, F Schilbach, H Schofield The economics of poverty traps, 57-118, 2017 | 141 | 2017 |
| Government fragmentation and public goods provision G Grossman, JH Pierskalla, E Boswell Dean The Journal of Politics 79 (3), 823-840, 2017 | 112 | 2017 |
| Food insecurity, health care utilization, and health care expenditures EB Dean, MT French, K Mortensen Health services research 55, 883-893, 2020 | 103 | 2020 |
| Physician, practice, and patient characteristics associated with biosimilar use in Medicare recipients EB Dean, P Johnson, AM Bond JAMA network open 4 (1), e2034776-e2034776, 2021 | 26 | 2021 |
| Using administrative data to examine telemedicine usage among Medicaid beneficiaries during the coronavirus disease 2019 pandemic M Hossain, EB Dean, D Kaliski Medical care 60 (7), 488-495, 2022 | 15 | 2022 |
| Who benefits from pharmaceutical price controls? Evidence from India EB Dean Center for Global Development, 2019 | 14 | 2019 |
| The future of global health procurement: issues around pricing transparency M Berdud, K Chalkidou, EB Dean, J Ferraro, L Garrison, C Nemzoff, ... Center for Global Development 50 (7), 27-31, 2019 | 12 | 2019 |
| The Role Of Financial Incentives In Biosimilar Uptake In Medicare: Evidence From The 340B Program: Study examines the role of financial incentives in the uptake of biosimilar … AM Bond, EB Dean, SM Desai Health Affairs 42 (5), 632-641, 2023 | 11 | 2023 |
| Trends in health care utilization and expenditures in the United States across 5 decades: 1977–2017 K Mortensen, EB Dean, MT French, N Wang, J Chen Medical care 59 (8), 704-710, 2021 | 7 | 2021 |
| The economics of poverty traps EB Dean, F Schilbach, H Schofield Chicago, IL: University of Chicago Press) Poverty and cognitive function, 2018 | 7 | 2018 |
| Poverty and cognitive function The Economics of Poverty Traps EB Dean, F Schilbach, H Schofield University of Chicago Press, 2017 | 6 | 2017 |
| Who benefits from pharmaceutical price ceilings EB Dean Evidence from India, 2017 | 5 | 2017 |
| Changes in Medicare part B spending for biologic drugs after biosimilar entry into the market EB Dean, AM Bond JAMA health forum 2 (9), e212634-e212634, 2021 | 4 | 2021 |
| Role of supply chain intermediaries in steering hospital product choice: Group Purchasing Organizations and biosimilars EB Dean, R Pierre, S Carter, AM Bond Health Affairs Scholar 2 (6), 2024 | 2 | 2024 |
| Stocking under the influence: spillovers from commercial drug coverage to Medicare utilization EB Dean, J Feng, L Maini Social Science Research Network [preprint on the Internet], 2023 | 1 | 2023 |
| Institutional Innovation for Neglected Diseases: The Case of the Priority Review Voucher LX Wang, E Dean, S Sylvia ASHEcon 2024 Conference, 2024 | | 2024 |
| Opioids and Health E Dean, Y Ge 2023 APPAM Fall Research Conference, 2023 | | 2023 |
| Financial Incentives In Biosimilar Uptake: The Authors Reply: A response letter to the Editor about financial incentives in biosimilar uptake AM Bond, EB Dean, S Desai Health Affairs 42 (9), 1308-1308, 2023 | | 2023 |
| Dengvaxia Controversy and Children's Vaccination in the Philippines J Yang, E Dean 2023 World Congress on Health Economics, 2023 | | 2023 |
| To Pool or Not to Pool? National Vs. Global Incentives in Pooled Purchasing E Dean, E Saltzman 2023 World Congress on Health Economics, 2023 | | 2023 |
